We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG.RT
12576
Bristol-Myers Squibb Rights
CELG.RT
$224M
$5K ﹤0.01%
37,954
-87,142
-70% -$11.5K
ITP icon
12577
PUT
IT Tech Packaging
ITP
$2.91M
$5K ﹤0.01%
+3,900
New +$8.93K
YCBD icon
12578
PUT
cbdMD
YCBD
$5.2M
$5K ﹤0.01%
+32
New +$7.58K
GHSI
12579
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$5K ﹤0.01%
693
-646
-48% -$5.65K
SLACW
12580
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$5K ﹤0.01%
32,429
-32
-0.1% -$10
PRPC.WS
12581
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$5K ﹤0.01%
17,932
-50,279
-74% -$22.8K
FATH.WS
12582
DELISTED
Fathom Digital Manufacturing Corporation Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
FATH.WS
$5K ﹤0.01%
13,776
+303
+2% +$201
SIOX
12583
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$5K ﹤0.01%
14,000
-10,700
-43% -$4.43K
IBER.WS
12584
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$5K ﹤0.01%
62,567
-304,560
-83% -$52.5K
ASAP
12585
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$5K ﹤0.01%
1,806
-5,698
-76% -$25.2K
AEACW
12586
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
$5K ﹤0.01%
52,389
-199,588
-79% -$39.4K
STAB
12587
CALL
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$5K ﹤0.01%
+19,200
New +$4.96K
QNGY
12588
PUT
DELISTED
Quanergy Systems, Inc.
QNGY
$5K ﹤0.01%
585
-2,120
-78% -$47.6K
AXU
12589
PUT
DELISTED
Alexco Resource Corp
AXU
$5K ﹤0.01%
+13,600
New +$13.2K
CNET icon
12590
CALL
ZW Data Action Technologies
CNET
$4.73M
$4K ﹤0.01%
595
-1,775
-75% -$15.3K
CRBP icon
12591
PUT
Corbus Pharmaceuticals
CRBP
$195M
$4K ﹤0.01%
493
-937
-66% -$9.06K
SONN
12592
DELISTED
Sonnet BioTherapeutics
SONN
$4K ﹤0.01%
6
-159
-96% -$114K
XTIA icon
12593
XTI Aerospace
XTIA
$62.3M
0
CSTA.WS
12594
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$4K ﹤0.01%
28,089
-707,732
-96% -$138K
NVSAW
12595
DELISTED
New Vista Acquisition Corp. Warrant
NVSAW
$4K ﹤0.01%
32,205
+1,072
+3% +$232
FOXWW
12596
DELISTED
FoxWayne Enterprises Acquisition Corp. Warrant
FOXWW
$4K ﹤0.01%
83,918
+200
+0.2% +$13
AVCT
12597
PUT
DELISTED
American Virtual Cloud Technologies, Inc. Common Stock
AVCT
$4K ﹤0.01%
1,073
-1,894
-64% -$15K
DLCAW
12598
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$4K ﹤0.01%
39,909
-24
-0.1% -$4
ASAXW
12599
DELISTED
Astrea Acquisition Corp. Warrant
ASAXW
$4K ﹤0.01%
48,758
-802
-2% -$107
FLYA.WS
12600
DELISTED
SOAR Technology Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FLYA.WS
$4K ﹤0.01%
32,434
-334,497
-91% -$63.5K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.